Alastair David Griffiths Lawson

This inventor holds 37 USPTO granted patents and 11 published patent applications, plus 5 CIPO patents and 16 EPO patents, primarily in Therapeutic Antibodies. Top assignees: Ucb Biopharma Sprl, Ucb Pharma, S.a., Ucbbiopharma Srl. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alastair David Griffiths Lawson. Retrieved from https://idiyas.com/inventor/alastair-david-griffiths-lawson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 37 (Patent Applications = 11)

% Patents Active = 56.8

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 16 (Patent Applications = 22)

Average Co-Inventor Count = 3.1

ph-index = 9

Forward Citations = 416(Granted Patents)

Location History:

Arlesford, GB (1999)
Slough Berkshire, GB (2012)
Alresford, GB (2006 - 2015)
Hampshire, GB (2009 - 2017)
Berkshire, GB (2019)
Slough, GB (2010 - 2024)

Company Filing History:

Celltech Therapeutics Limited

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Areas of Expertise:

Anti-FcRn Antibodies

Therapeutic Ligand

Single Chain FC Polypeptides

IL-17A Binding

TNF Alpha Complex

OX40 Specificity

Pain Treatment

Nucleic Acids

Synthetic Components

Antibody Production

Inflammation Treatment

Ion Channel Antibodies

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12338285 - Anti-FcRn antibodies (2025-06-24),

2. 12327614 - Multi-domain proteins with increased native state colloidal stability (2025-06-10),

3. 11942188 - Obtaining an improved therapeutic ligand (2024-03-26),

4. 11919950 - Expression vector encoding antibody molecule which binds IL-17A and IL-17F (2024-03-05),

5. 11384148 - Anti-FcRn antibodies (2022-07-12),

6. 11174311 - Antibody against trimeric TNFα complex (2021-11-16),

7. 10479824 - Single chain FC polypeptides (2019-11-19),

8. 10233243 - Anti-FcRn antibodies (2019-03-19),

9. 10112996 - [object Object] (2018-10-30),

10. 10048253 - Method for identifying compounds of therapeutic interest (2018-08-14),

11. 10017575 - Antibody molecules having specificity for human OX40 (2018-07-10),

12. 9988446 - Methods of treatment using antibodies which bind IL-17A and IL-17F (2018-06-05),

13. 9957320 - Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13 (2018-05-01),

14. 9840556 - Anti-TNF alpha antibodies which selectively inhibit TNF alpha signalling through the p55R (2017-12-12),

15. 9738710 - Method of treating a patient for pain by administering an anti-ion channel antibody (2017-08-22),

Title: Alastair David Griffiths Lawson - Inventor from Slough, GB

Introduction: Alastair David Griffiths Lawson is a renowned inventor hailing from Slough, Great Britain. With a passion for innovation and a keen eye for problem-solving, Lawson has made significant contributions to various fields through his inventive spirit.

Latest Patents: Alastair David Griffiths Lawson holds several patents in the areas of renewable energy technologies, sustainable packaging solutions, and advanced materials science. His recent patents showcase his commitment to creating a more sustainable and efficient future.

Career Highlights: Throughout his career, Alastair David Griffiths Lawson has worked with leading research institutions and companies to bring his inventions to life. His innovative approach has led to the development of groundbreaking technologies that have the potential to revolutionize industries.

Collaborations: Lawson has collaborated with top universities and research institutions worldwide to further his research and bring his inventions to the market. His partnerships with industry experts and fellow inventors have resulted in successful projects that have garnered international recognition.

Conclusion: Alastair David Griffiths Lawson's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His pioneering work continues to inspire future generations of inventors and shape the landscape of technological advancement.

Profile summary based on public USPTO records.